跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

GLAXOSMITHKLINE SA

首页临床试验发起方与机构GLAXOSMITHKLINE SA

GLAXOSMITHKLINE SA

CALLE DE SEVERO OCHOA (- PQ TECNOLOGICO DE MADRID) 2, Tres Cantos, Madrid, 西班牙

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

相关临床试验

228

228 进行中

药物批准

233

批准总数

监管机构

2

监管机构数

成立时间

N/A

概览

试验阶段分布

阶段

试验数

占比

1 期

171

75.0%

试验状态分布

进行中（未招募）

228

100.0%

相关临床试验

该机构主办的试验（228）

A study on the reactogenicity, safety, immune response, and efficacy of a vaccine against HSV-2 in healthy participants aged 18-40 years or in participants aged 18-60 years with recurrent HSV-2 genital herpes

进行中（未招募）

Apr 2022332 名受试者

Investigation of depemokimab (GSK3511294) in patients with chronic rhinosinusitus with nasal polyps (CRSwNP).

进行中（未招募）

Feb 2022250 名受试者

OPAL Master ProtocolPhase 1B/2 Multicohort Umbrella Study to Evaluate the Safety and Efficacy of Novel Treatments and/or Combinations of Treatments in Participants with Ovarian Cancer (OPAL).OPAL-Supplement CCohort C: Open-Label Phase 2, Randomized, Controlled Multicenter Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants with Homologous Recombination-Deficient Stage III/IV Ovarian Cancer.

进行中（未招募）

Dec 202184 名受试者

A study on the safety, efficacy and immune response following sequential treatment with an anti-sense oligonucleotide against chronic Hepatitis B (CHB) and chronic Hepatitis B targeted immunotherapy (CHB-TI) in CHB patients receiving nucleos(t)ide analogue (NA) therapy.

进行中（未招募）

Nov 2021184 名受试者

A study to evaluate the safety and immune response to an unadjuvanted RSV maternal vaccine in healthy non-pregnant females from 9 to 49 years of age.

进行中（未招募）

Nov 2021252 名受试者

Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants with Relapsed or Refractory Multiple Myeloma (DREAMM-14)

进行中（未招募）

Oct 2021102 名受试者

A study on the safety, tolerability and immune response of meningococcal combined ABCWY vaccine in healthy infants.

进行中（未招募）

Jul 2021688 名受试者

A Phase III study to assess the lot-to-lot consistency of GSK’s investigational RSV maternal vaccine and the immune response and safety of RSV maternal vaccine when given alone or co-administered with GSK’s influenza D-QIV vaccine in healthy non-pregnant women.

进行中（未招募）

Jun 20211541 名受试者

第 1 页，共 29 页

药物批准

按机构分类的批准

NMPA

National Medical Products Administration

12

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

221

药物批准

近期批准

SHINGRIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA

BLENREP 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Ropinirole Hydrochloride Sustained-release Tablets

Ropinirole Hydrochloride Sustained-release Tablets

FLUARIX SUSPENSION INYECTABLE EN JERINGA PRECARGADA

MENVEO SOLUCION INYECTABLE

ZEJULA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

OMJJARA 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

OMJJARA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

OMJJARA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

资讯

暂无资讯文章

本页目录

概览
相关临床试验228
药物批准233
资讯

返回机构列表